ALK7, the company’s investigational RNA interference therapeutic targeting Activin receptor-like kinase 7 being developed as a potential treatment for obesity. The results were presented in a poster ...
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced preclinical results on ARO-ALK7, the company’s investigational RNA interference (RNAi) therapeutic targeting Activin receptor-like kinase ...
Who will replace Ohio Gov. Mike DeWine in 2027? The race for Ohio governor has already begun with several candidates throwing their hats in the political ring. DeWine cannot run for reelection in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results